PUNE: Top experts in the country have backed the Centre’s stance on completion of nine months after the second shot of Covid vaccine for availing a precaution dose. A study…
By Mike Corder The Hague, Dec 20 (AP) The European Union’s drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting…
New Delhi: Pharma major AstraZeneca announced that its long-acting antibody combination for the prevention of COVID-19, Evusheld, retained neutralizing activity against the newly detected variant Omicron according to the preclinical…
By Mrinalika Roy and Pushkala Aripaka AstraZeneca and Regeneron on Thursday reported contrasting data on the effectiveness of their COVID-19 antibody therapies against the Omicron variant of the coronavirus, underscoring…
BRUSSELS: Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of Covid-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows…
Biopharmaceutical multinational AstraZeneca on Thursday said it has initiated engagements with Indian health authorities to provide the latest evidence of Evusheld, its COVID-19 prevention drug for people with weakened immune…
New Dehi : AstraZeneca’s Evusheld received emergency use authorization (EUA) from United States Food and Drug Administration (FDA) for the pre-exposure prevention of COVID-19. The first doses of the long-acting…
By Pushkala Aripaka and Lucy Marks A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of…
British-Swedish drugmaker AstraZeneca said it is studying the effectiveness of its Vaxzevria Covid-19 vaccine against the Omicron variant of the coronavirus. The company, along with Oxford University, has developed a…
India is not considering authorising booster COVID-19 doses yet as many in the country have been naturally infected and the government believes two doses of a vaccine offers sufficient protection…
